{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T11:19:28Z","timestamp":1780485568753,"version":"3.54.1"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"DOI":"10.7759\/cureus.36305","type":"journal-article","created":{"date-parts":[[2023,3,17]],"date-time":"2023-03-17T19:41:12Z","timestamp":1679082072000},"source":"Crossref","is-referenced-by-count":1,"title":["Spontaneous Tumor Lysis Syndrome in a Patient With a Known History of Chronic Lymphocytic Leukemia Prior to Cytotoxic Chemotherapy"],"prefix":"10.7759","author":[{"given":"Marcus","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21654","article-title":"Cancer statistics, 2021","volume":"71","author":"Siegel RL","year":"2021","unstructured":"Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer statistics, 2021. CA Cancer J Clin. 2021, 71:7-33. 10.3322\/caac.21654","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-09-806398","article-title":"iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL","volume":"131","author":"Hallek M","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, et al.. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018, 131:2745-60. 10.1182\/blood-2017-09-806398","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2004.05094.x","article-title":"Tumour lysis syndrome: new therapeutic strategies and classification","volume":"127","author":"Cairo MS","year":"2004","unstructured":"Cairo MS, Bishop M. Tumour lysis syndrome: new therapeutic strategies and classification. Br J Haematol. 2004, 127:3-11. 10.1111\/j.1365-2141.2004.05094.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-08-207126","article-title":"How I treat CLL up front","volume":"115","author":"Gribben JG","year":"2010","unstructured":"Gribben JG. How I treat CLL up front. Blood. 2010, 115:187-97. 10.1182\/blood-2009-08-207126","journal-title":"Blood"},{"key":"ref5","unstructured":"National Comprehensive Cancer Network. Chronic lymphocytic leukemia\/small lymphocytic lymphoma (version 2.2022). (2022). Accessed: January 31, 2022: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/cll.pdf."},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-19-1130","article-title":"Acalabrutinib plus obinutuzumab in treatment-na\u00efve and relapsed\/refractory chronic lymphocytic leukemia","volume":"10","author":"Woyach JA","year":"2020","unstructured":"Woyach JA, Blachly JS, Rogers KA, et al.. Acalabrutinib plus obinutuzumab in treatment-na\u00efve and relapsed\/refractory chronic lymphocytic leukemia. Cancer Discov. 2020, 10:394-405. 10.1158\/2159-8290.CD-19-1130","journal-title":"Cancer Discov"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-021-01188-x","article-title":"Concurrent ibrutinib plus venetoclax in relapsed\/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study","volume":"14","author":"Wang M","year":"2021","unstructured":"Wang M, Ramchandren R, Chen R, et al.. Concurrent ibrutinib plus venetoclax in relapsed\/refractory mantle cell lymphoma: the safety run-in of the phase 3 SYMPATICO study. J Hematol Oncol. 2021, 14:179. 10.1186\/s13045-021-01188-x","journal-title":"J Hematol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1159\/000509643","article-title":"Spontaneous tumor lysis syndrome","volume":"13","author":"Wesem\u00fcller W","year":"2020","unstructured":"Wesem\u00fcller W, Taverna C. Spontaneous tumor lysis syndrome. Case Rep Oncol. 2020, 13:1116-24. 10.1159\/000509643","journal-title":"Case Rep Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11279","article-title":"A needle in the haystack: a rare case of spontaneous tumor lysis in newly diagnosed chronic lymphocytic leukemia unmasked by acute renal failure","volume":"12","author":"Desai M","year":"2020","unstructured":"Desai M, Parsi M, Potdar R, Sanjay R. A needle in the haystack: a rare case of spontaneous tumor lysis in newly diagnosed chronic lymphocytic leukemia unmasked by acute renal failure. Cureus. 2020, 12:e11279. 10.7759\/cureus.11279","journal-title":"Cureus"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12659\/AJCR.917211","article-title":"Tumor lysis syndrome in chronic lymphocytic leukemia: a rare case report from nephrology","volume":"20","author":"Armaly Z","year":"2019","unstructured":"Armaly Z, Elias M, Yasin R, Hamzeh M, Jabbour AR, Artoul S, Saffouri A. Tumor lysis syndrome in chronic lymphocytic leukemia: a rare case report from nephrology. Am J Case Rep. 2019, 20:1776-80. 10.12659\/AJCR.917211","journal-title":"Am J Case Rep"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198105000-00005","article-title":"Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas","volume":"60","author":"Tsokos GC","year":"1981","unstructured":"Tsokos GC, Balow JE, Spiegel RJ, Magrath IT. Renal and metabolic complications of undifferentiated and lymphoblastic lymphomas. Medicine (Baltimore). 1981, 60:218-29. 10.1097\/00005792-198105000-00005","journal-title":"Medicine (Baltimore)"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1001\/archinte.1974.00320150023002","article-title":"Hyperuricemic acute renal failure","volume":"133","author":"Kjellstrand CM","year":"1974","unstructured":"Kjellstrand CM, Cambell DC II, von Hartitzsch B, et al.. Hyperuricemic acute renal failure. Arch Intern Med. 1974, 133:349-59.","journal-title":"Arch Intern Med"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1182\/blood.v97.10.2998","article-title":"A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis","volume":"97","author":"Goldman SC","year":"2001","unstructured":"Goldman SC, Holcenberg JS, Finklestein JZ, et al.. A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis. Blood. 2001, 97:2998-3003. 10.1182\/blood.v97.10.2998","journal-title":"Blood"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0904569","article-title":"The tumor lysis syndrome","volume":"364","author":"Howard SC","year":"2011","unstructured":"Howard SC, Jones DP, Pui CH. The tumor lysis syndrome. N Engl J Med. 2011, 364:1844-54. 10.1056\/NEJMra0904569","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.15.0177","article-title":"Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review","volume":"26","author":"Coiffier B","year":"2008","unstructured":"Coiffier B, Altman A, Pui CH, Younes A, Cairo MS. Guidelines for the management of pediatric and adult tumor lysis syndrome: an evidence-based review. J Clin Oncol. 2008, 26:2767-78. 10.1200\/JCO.2007.15.0177","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/94495-spontaneous-tumor-lysis-syndrome-in-a-patient-with-a-known-history-of-chronic-lymphocytic-leukemia-prior-to-cytotoxic-chemotherapy","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:54:42Z","timestamp":1707508482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/94495-spontaneous-tumor-lysis-syndrome-in-a-patient-with-a-known-history-of-chronic-lymphocytic-leukemia-prior-to-cytotoxic-chemotherapy"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,17]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.36305","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,17]]}}}